Excellent questions Werble, but don't hold your breath for the answers, this company has a history of saying very little. You would have to ask the question - why?
And there is another question you could ask - when/if it gets its product to market (and that is a long, long, way away), how will the company make money from it? Curative medications have very low potential for making profits.Management therapies that require repetitive, long term use are what manufacturers (big pharma) make their money from.
Recce is a minnow in the new antibiotic field where a number of billion dollar heavyweights have already gone bust - exactly why Recce believes it can succeed where these heavily funded, long established, behemoths have failed is difficult to understand - and they are certainly not telling us.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)